GIST

patient care perspectives

by Suzanne George, MD

The treatment of advanced gastrointestinal stromal tumors (GIST) has improved in recent years with the introduction of tyrosine kinase inhibitors (......READ MORE

patient care perspectives

by Richard F. Riedel, MD

Late-line tyrosine kinase inhibitor (TKI) dose escalation may benefit a subset of patients with gastrointestinal stromal tumors (GIST), allowing fo......READ MORE

patient care perspectives

by Jonathan C. Trent, MD, PhD

Patients with advanced and metastatic gastrointestinal stromal tumors (GIST) vary in their symptom burden. The treatment of the GIST itself helps t......READ MORE

patient care perspectives

by Arun Singh, MD

Educational efforts and counseling by physicians and support staff can help to manage patient expectations and provide emotional support to newly d......READ MORE

patient care perspectives

by Jonathan C. Trent, MD, PhD

The diagnosis of gastrointestinal stromal tumors (GIST) is based on an evaluation that identifies a mass and leads to biopsy. Symptoms at presentat......READ MORE